Single Ascending Dose Study of MEDI1341 in Healthy Volunteers

Trial Identifier:	D6340C00001
Sponsor:	AstraZeneca
Collaborator:	Covance, Inc MMS Holdings, Inc Catalent Pharma Solutions Takeda Pharmaceutical Company Ltd
Start Date:	October 2017
Primary Completion Date:	March 2021
Study Completion Date:	March 2021
Condition:	Neurological & Brain - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, TX	Dallas, TX, US, 75247
US, WI	Madison, WI, US, 53704

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.